146 related articles for article (PubMed ID: 38409829)
1. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract][Full Text] [Related]
2. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
3. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
4. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
5. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
[TBL] [Abstract][Full Text] [Related]
6. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
9. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
10. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
11. Ovarian sex cord-stromal tumours: an update in recent molecular advances.
Lim D; Oliva E
Pathology; 2018 Feb; 50(2):178-189. PubMed ID: 29275930
[TBL] [Abstract][Full Text] [Related]
12. Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
Kommoss FKF
Histopathology; 2024 Mar; 84(4):712-714. PubMed ID: 38114269
[TBL] [Abstract][Full Text] [Related]
13. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract][Full Text] [Related]
14. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
[TBL] [Abstract][Full Text] [Related]
15. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract][Full Text] [Related]
17. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
Haley M; Bindal P; McAuliffe A; Vredenburgh J
Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
[TBL] [Abstract][Full Text] [Related]
18. DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
Lau JCC; McCluggage WG; Yuen LYP; Shing MMK; Chan GCF; Yam FSD; Leung MWY; Ng WF; Liu APY
Int J Gynecol Pathol; 2023 Jul; 42(4):421-425. PubMed ID: 36044308
[TBL] [Abstract][Full Text] [Related]
19. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
20. Case report: an identical twin with Sertoli-Leydig cell tumor.
Cho K; Havelock JC; Gilks B; Dunne C
Gynecol Endocrinol; 2018 Jul; 34(7):563-566. PubMed ID: 29366348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
